| Kotak S&P BSE SENSEX ETF
An open-ended scheme replicating/ tracking S&P BSE sensex index
NSE Symbol - KTKSENSEX
BSE Scrip Code - 532985
| Kotak S&P BSE SENSEX ETF
An open-ended scheme replicating/ tracking S&P BSE sensex index
NSE Symbol - KTKSENSEX
BSE Scrip Code - 532985

      

      
Investment Objective
The investment objective of the scheme is to provide returns before expenses that closely correspond to the total returns of the BSE SENSEX subject to tracking errors. However, there is no assurance or guarantee that the investment objective of the scheme will be achieved.
The investment objective of the scheme is to provide returns before expenses that closely correspond to the total returns of the BSE SENSEX subject to tracking errors. However, there is no assurance or guarantee that the investment objective of the scheme will be achieved.
Issuer/Instrument Industry/
Rating
% to Net
Assets

Equity & Equity Related
Reliance Industries Ltd. Petroleum Products 13.28
HDFC Bank Ltd. Banks 9.65
ICICI Bank Ltd. Banks 8.73
Infosys Ltd. IT - Software 8.70
HDFC Ltd. Finance 6.62
Tata Consultancy Services Ltd. IT - Software 5.19
ITC Ltd. Diversified FMCG 4.07
Kotak Mahindra Bank Ltd. Banks 3.64
Hindustan Unilever Ltd. Diversified FMCG 3.61
Larsen And Toubro Ltd. Construction 3.35
State Bank Of India Banks 3.11
Axis Bank Ltd. Banks 3.04
Bajaj Finance Ltd. Finance 2.95
Bharti Airtel Ltd Telecom - Services 2.51
Asian Paints Ltd. Consumer Durables 2.30
Maruti Suzuki India Limited Automobiles 1.79
Mahindra & Mahindra Ltd. Automobiles 1.71
HCL Technologies Ltd. IT - Software 1.58
Sun Pharmaceuticals Industries Ltd. Pharmaceuticals & Biotechnology 1.56
Titan Company Ltd. Consumer Durables 1.51
Bajaj Finserv Ltd. Finance 1.39
Tata Steel Ltd. Ferrous Metals 1.31
Ultratech Cement Ltd. Cement & Cement Products 1.16
Power Grid Corporation Of India Ltd. Power 1.12
National Thermal Power Corporation Limited Power 1.11
Nestle India Ltd. Food Products 1.06
Tech Mahindra Ltd. IT - Software 1.00
IndusInd Bank Ltd. Banks 0.97
Wipro Ltd. IT - Software 0.96
Dr Reddys Laboratories Ltd. Pharmaceuticals & Biotechnology 0.76
Equity & Equity Related - Total 99.74
Net Current Assets/(Liabilities) 0.26
Grand Total 100.00

NAV
Rs60.7363

Available Plans/Options

Regular Plan


Fund Manager Mr. Devender Singhal &
Mr. Satish Dondapati*
BenchmarkS&P BSE SENSEX TRI
Allotment dateJune 6, 2008
AAUMRs20.33 crs
AUMRs21.38 crs
Folio count1,543

Ratios
Portfolio Turnover12.73%
Tracking Error:0.04%

Minimum Investment Amount

Through Exchange: 1 Unit ,
Through AMC: 10000 Units,
Ideal Investment Horizon: 5 years and above


Load Structure

Entry Load: Nil. (applicable for all plans)
Exit Load: Nil (applicable for all plans)


Total Expense Ratio**

Regular: 0.28%


Data as on July 31, 2022

Fund


Benchmark


This product is suitable for investors who are seeking*:
  • Long term capital growth
  • Investment in stocks comprising the underlying index and endeavours to track the benchmark index

* Investors should consult their financial advisers if in doubt about whether the product is suitable for them.


**Total Expense Ratio includes applicable B30 fee and GST.
* For Fund Manager experience, please refer 'Our Fund Managers'
For last three IDCW, please refer 'Dividend History'.
For scheme performance, please refer 'Scheme Performances'